Developer docs
API playgroundTry for free, no card

Search company profiles

Sick Cells

Full company profile

uuid005b7bg

Namestring
Sick Cells
Legal namestring
Sick Cells
Websiteurl
sickcells.org
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Sick Cells is a national 501(c)(3) nonprofit advocacy organization founded in 2017 and headquartered in Washington, DC, with an additional office in Wheaton, Illinois and a recently opened Maryland presence. The organization's mission is to elevate the voices of people living with sickle cell disease (SCD) and their families through advocacy, storytelling, and direct engagement with state and federal policymakers. It serves SCD patients across all hemoglobin types, caregivers, family members, and trained patient advocates, with secondary engagement of community-based organizations, legislators, and Medicaid officials.

The organization's core programs are the Ambassador Program, which recruits and trains a national network of volunteer SCD patient advocates (over 100 engaged nationally), and the Faces of SCD Storytelling Program, which has documented 65+ patient stories. It also maintains an interactive advocacy map covering all 50 US states plus DC, a research and publications arm producing original patient surveys (including a 547-respondent survey submitted to ICER) and Medicaid coverage analyses, and specialized initiatives such as the Hispanic Outreach Promoting Equity (HOPE) Project, Project SCoviD, and a Caregiver Resources Help Desk in partnership with Caregiver Action Network. Technology is not a component of the offering; the platform is human-driven community organizing and policy work.

Sick Cells is funded through three revenue streams: individual donations, corporate sponsorships (Pfizer Gold; Chiesi, Novo Nordisk, and Vertex Pharmaceuticals Silver; Beam Therapeutics Bronze; plus additional pharma supporters and a Corporate Advisory Council), and grants (PCORI Engagement Award, Global Genes Rare Health Equity Grant). All programs, toolkits, and resources are provided free of charge to the SCD community. The organization has earned recognition including the 2025 ASH Outstanding Service Award and has been featured in The New York Times and The New Yorker.

Short descriptiontext

Sick Cells is a national 501(c)(3) nonprofit advocacy organization that elevates the voices of people living with sickle cell disease through the Ambassador Program, Faces of SCD storytelling, and direct engagement with state and federal policymakers on coverage and access.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWheaton, United States
HQ citystring
Wheaton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sickle cell advocacy, patient advocacy, health policy, rare disease nonprofit, community organizing
Industry2 codes
PRIMARYBPAGACAH
Patient Advocacy, Navigation & Access to Care
SECONDARYBPAGACAM
Rare Disease & Special Needs Support Organizations
NAICS code1 code
  • Individual and Family Services6241
SIC code2 codes
  • Services-Social Services8300
  • Services-Health Services8000
Product category
Patient Advocacy Services
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Individual Donations
TypeOthers
Description

Sick Cells accepts individual donations through its website to fund operations and programs. Donations support the organization's mission of elevating the sickle cell community's voices through advocacy, storytelling, and policy work.

sickcells.org
2Corporate Sponsorship
TypeOthers
Description

Sick Cells is funded by pharmaceutical companies including Pfizer (Gold), Chiesi (Silver), Novo Nordisk (Silver), Vertex Pharmaceuticals (Silver), Beam Therapeutics (Bronze), and supporters including Agios Pharmaceuticals, Bristol Myers Squibb, Fulcrum Therapeutics, and Genetix Biotherapeutics. The organization also maintains a Corporate Advisory Council with members at various tiers (Champion, Founder, Leader, Friend).

sickcells.org
3Grant Funding
TypeGrants Donations
Description

Sick Cells has received grant funding including from the PCORI Engagement Award and the Global Genes Rare Health Equity Grant for the Hispanic Outreach Promoting Equity (HOPE) Project.

sickcells.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Sick Cells is a national 501(c)(3) nonprofit organization that advocates for the sickle cell disease (SCD) community through storytelling, policy engagement, and community organizing. The organization operates programs including the Ambassador Program, which trains volunteer SCD advocates, and the Faces of SCD Storytelling Program, which documents patient stories. It also produces research publications, advocacy toolkits, and educational resources provided free of charge to patients, caregivers, and policymakers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 100 SCD advocates recruited and engaged nationally through the Ambassador Program
+3 more records
Product overview1 text field

Sick Cells is a national advocacy nonprofit for sickle cell disease (SCD) that operates a collection of programs and resources rather than a traditional product platform. Its core offerings include the Ambassador Program, which trains volunteer advocates to educate and mobilize the SCD community, and the Faces of SCD Storytelling Program, which documents patient stories to eliminate stigma. The organization also provides an extensive Advocacy Tools library with state-specific resources, a Sickle Cell Resources library with educational materials, and specialized initiatives like Project SCoviD for COVID-19 outreach, the Caregiver Resources Help Desk in partnership with Caregiver Action Network, and the Hispanic Outreach Promoting Equity (HOPE) Project. Research publications covering Medicaid access, health equity, and patient burden support the organization's advocacy mission.

Product and service7 records
1Ambassador Program
CategoryAdvocacy Program
Description

A volunteer network of sickle cell advocates that provides training and tools to educate the SCD community, connect stakeholders, and activate advocacy through partnerships and ongoing communication.

2Faces of SCD Storytelling Program
CategoryStorytelling Program
Description

A storytelling initiative that documents and elevates the voices of people living with sickle cell disease and their support systems to highlight resilience and eliminate stigma.

3Advocacy Tools and Toolkits
CategoryResource Library
Description

A collection of advocacy toolkits, state-specific resources, and interactive maps providing guidance for individuals to develop and implement sickle cell advocacy strategies at local and federal levels.

4Sickle Cell Resources Library
CategoryResource Library
Description

A comprehensive library of sickle cell disease education materials, data research, clinical guidelines, and treatment information for patients, caregivers, and medical professionals.

5Hispanic Outreach Promoting Equity (HOPE) Project
CategoryOutreach Initiative
Description

A project focused on understanding how race and ethnicity impact the experiences of Hispanic individuals with sickle cell disease, including educational tools and roundtable discussions.

6Research Publications
CategoryResearch
Description

Reports, white papers, surveys, and research findings on Medicaid access, health equity, patient preferences, and the burden of sickle cell disease to drive advocacy work.

7Caregiver Resources and Help Desk
CategorySupport Service
Description

A partnership with Caregiver Action Network providing resources, a help desk, journey maps, and support services for caregivers of people living with sickle cell disease.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sick Cells is a member of the Sickle Cell Disease Association of America, a national organization representing the sickle cell community. Sick Cells collaborates with SCDAA on policy forums, legislative advocacy, and community organizing efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sick Cells holds Platinum membership in NORD, the leading independent organization representing the 25-30 million Americans with rare diseases. This membership supports Sick Cells' advocacy within the broader rare disease community.

3Innovation and Value Initiative (IVI)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sick Cells partnered with IVI to publish a joint white paper on Finding Equity in Value, contributing the patient and sickle cell community perspective to value assessment methodologies in healthcare.

sickcells.org
4Sickle Cell Disease Coalition
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sick Cells is a member of the Sickle Cell Disease Coalition, a group of organizations working to advance policies and research for the SCD community.

sickcells.org
5Blood Health Network (NHLBI)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells is a member of the Blood Health Network, an initiative of the National Heart, Lung, and Blood Institute (NHLBI) focused on blood health education and awareness.

sickcells.org
6Rare Hub by EveryLife Foundation
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells participates in the Rare Hub by EveryLife Foundation, which provides resources and advocacy support for rare disease communities.

sickcells.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Vertex Pharmaceuticals is a Silver Level sponsor of Sick Cells. Sick Cells collaborated with Vertex on the Health-Related Quality of Life Survey for sickle cell disease patients, and Vertex is developing gene therapies for SCD (exa-cel).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Quilt Health is a Founder Level member of Sick Cells' Corporate Advisory Council, providing strategic support to the organization's mission.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells collaborated with the University of Pittsburgh to study barriers to accessing disease-modifying treatments for sickle cell disease.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Sick Cells contracted Artia Solutions to conduct comprehensive analyses of coverage policies for SCD therapies across all 50 state Medicaid programs and managed care organizations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells collaborated with USC HUGS as part of the PCORI Engagement Award to identify and assess core elements of value for SCD research measures.

12Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells collaborated with the CHOICE Institute at University of Washington School of Pharmacy on defining value and supporting equity in sickle cell disease research.

sickcells.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells partnered with QC Medica to survey individuals living with sickle cell disease on the impacts of the disease on quality of life and health quality.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells collaborated with NDMP and SC RED on the Transplant Equity and Awareness for Sickle Cell Disease (TEA for SCD) project to increase stem cell donation awareness.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells partnered with SC RED on the TEA for SCD project to raise awareness about bone marrow transplant as a treatment option for sickle cell disease.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sick Cells partnered with Caregiver Action Network to provide comprehensive resources and a Help Desk for sickle cell disease caregivers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1National Hemophilia Foundation
TypeDirect peer
Description

A chronic-disease patient advocacy nonprofit that combines research funding, policy advocacy, and community programs — a similar integrated advocacy model to Sick Cells, though serving hemophilia rather than SCD. Comparable in structure, funding mix (pharma + individual donations), and policy focus on payer access.

TypeBroad incumbent
Description

A large disease-specific patient advocacy nonprofit combining research funding, community programs, and policy advocacy. Komen is a comparable model for Sick Cells at much greater scale, especially in grassroots mobilization and corporate partnership structures.

3American Sickle Cell Anemia Association (ASCAA)
TypeDirect peer
Description

A national SCD-focused nonprofit delivering patient education, community programs, and advocacy support. ASCAA is comparable to Sick Cells in mission and disease focus, with overlapping work in patient storytelling, awareness, and treatment-access advocacy.

TypeDirect peer
Description

A rare disease advocacy nonprofit focused on accelerating biotech innovation and access for rare disease communities. Directly comparable to Sick Cells in advocacy model — policy engagement, community mobilization, and federal agency comments — but operating across all rare diseases rather than a single condition.

TypeBroad incumbent
Description

A disease-specific patient advocacy nonprofit funding research, providing care services, and driving policy. MDA shares Sick Cells' integrated advocacy-plus-patient-services model and pharma-funded sponsorship structure, though at a much larger scale.

TypeBroad incumbent
Description

A large disease-specific patient advocacy nonprofit that funds research, drives policy, and supports patients. Highly comparable to Sick Cells in the integrated advocacy-plus-research-plus-community model, though much larger and focused on CF rather than SCD.

TypeBroad incumbent
Description

The largest US rare disease umbrella advocacy organization. Sick Cells holds Platinum membership in NORD; both engage in federal policy advocacy and community support, but NORD operates across all rare diseases while Sick Cells is disease-specific.

TypeDirect peer
Description

The longest-standing national SCD advocacy nonprofit, providing patient services, research, and policy advocacy. SCDAA is Sick Cells' most direct peer — both serve the same disease community with overlapping policy and community engagement mandates, though SCDAA is older and larger.

TypeDirect peer
Description

A long-running regional SCD nonprofit providing patient education, support services, and advocacy. It is comparable to Sick Cells as a sickle cell-focused advocacy and community-support organization, though it operates at a state rather than national scale.

10Sickle Cell Disease Coalition
TypeOthers
Description

An umbrella coalition of SCD-focused organizations in which Sick Cells is a member. Comparable as a convening body that aligns SCD advocacy efforts across member organizations, serving as an enabling/ecosystem participant rather than a direct competitor.

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sick Cells

Patient Advocacy Servicessickcells.org

Sick Cells is a national 501(c)(3) nonprofit advocacy organization that elevates the voices of people living with sickle cell disease through the Ambassador Program, Faces of SCD storytelling, and direct engagement with state and federal policymakers on coverage and access.

What Sick Cells does

Sick Cells is a national 501(c)(3) nonprofit advocacy organization founded in 2017 and headquartered in Washington, DC, with an additional office in Wheaton, Illinois and a recently opened Maryland presence. The organization's mission is to elevate the voices of people living with sickle cell disease (SCD) and their families through advocacy, storytelling, and direct engagement with state and federal policymakers. It serves SCD patients across all hemoglobin types, caregivers, family members, and trained patient advocates, with secondary engagement of community-based organizations, legislators, and Medicaid officials.

The organization's core programs are the Ambassador Program, which recruits and trains a national network of volunteer SCD patient advocates (over 100 engaged nationally), and the Faces of SCD Storytelling Program, which has documented 65+ patient stories. It also maintains an interactive advocacy map covering all 50 US states plus DC, a research and publications arm producing original patient surveys (including a 547-respondent survey submitted to ICER) and Medicaid coverage analyses, and specialized initiatives such as the Hispanic Outreach Promoting Equity (HOPE) Project, Project SCoviD, and a Caregiver Resources Help Desk in partnership with Caregiver Action Network. Technology is not a component of the offering; the platform is human-driven community organizing and policy work.

Sick Cells is funded through three revenue streams: individual donations, corporate sponsorships (Pfizer Gold; Chiesi, Novo Nordisk, and Vertex Pharmaceuticals Silver; Beam Therapeutics Bronze; plus additional pharma supporters and a Corporate Advisory Council), and grants (PCORI Engagement Award, Global Genes Rare Health Equity Grant). All programs, toolkits, and resources are provided free of charge to the SCD community. The organization has earned recognition including the 2025 ASH Outstanding Service Award and has been featured in The New York Times and The New Yorker.

Sick Cells firmographics

Firmographics
Name
Sick Cells
Legal name
Sick Cells
Website
https://sickcells.org
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Sick Cells is a national 501(c)(3) nonprofit advocacy organization that elevates the voices of people living with sickle cell disease through the Ambassador Program, Faces of SCD storytelling, and direct engagement with state and federal policymakers on coverage and access.
Ownership category
akta.pro rank

Sick Cells industry classification

Industry
Product category
Patient Advocacy Services
NAICS
Individual and Family Services (6241)
SIC
Services-Social Services (8300), Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGACAH
Patient Advocacy, Navigation & Access to Care
SECONDARYBPAGACAM
Rare Disease & Special Needs Support Organizations

Keywords

  • Sickle cell advocacy
  • Patient advocacy
  • Health policy
  • Rare disease nonprofit
  • Community organizing

Where Sick Cells is headquartered

Location

Headquarters

HQ city
Wheaton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Sick Cells business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Individual Donations: Sick Cells accepts individual donations through its website to fund operations and programs. Donations support the organization's mission of elevating the sickle cell community's voices through advocacy, storytelling, and policy work.
  2. Corporate Sponsorship: Sick Cells is funded by pharmaceutical companies including Pfizer (Gold), Chiesi (Silver), Novo Nordisk (Silver), Vertex Pharmaceuticals (Silver), Beam Therapeutics (Bronze), and supporters including Agios Pharmaceuticals, Bristol Myers Squibb, Fulcrum Therapeutics, and Genetix Biotherapeutics. The organization also maintains a Corporate Advisory Council with members at various tiers (Champion, Founder, Leader, Friend).
  3. Grant Funding: Sick Cells has received grant funding including from the PCORI Engagement Award and the Global Genes Rare Health Equity Grant for the Hispanic Outreach Promoting Equity (HOPE) Project.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Sick Cells product offering

Product offering

Core offering

Sick Cells is a national 501(c)(3) nonprofit organization that advocates for the sickle cell disease (SCD) community through storytelling, policy engagement, and community organizing. The organization operates programs including the Ambassador Program, which trains volunteer SCD advocates, and the Faces of SCD Storytelling Program, which documents patient stories. It also produces research publications, advocacy toolkits, and educational resources provided free of charge to patients, caregivers, and policymakers.

Product overview

Sick Cells is a national advocacy nonprofit for sickle cell disease (SCD) that operates a collection of programs and resources rather than a traditional product platform. Its core offerings include the Ambassador Program, which trains volunteer advocates to educate and mobilize the SCD community, and the Faces of SCD Storytelling Program, which documents patient stories to eliminate stigma. The organization also provides an extensive Advocacy Tools library with state-specific resources, a Sickle Cell Resources library with educational materials, and specialized initiatives like Project SCoviD for COVID-19 outreach, the Caregiver Resources Help Desk in partnership with Caregiver Action Network, and the Hispanic Outreach Promoting Equity (HOPE) Project. Research publications covering Medicaid access, health equity, and patient burden support the organization's advocacy mission.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ambassador Program A volunteer network of sickle cell advocates that provides training and tools to educate the SCD community, connect stakeholders, and activate advocacy through partnerships and ongoing communication.
  • Faces of SCD Storytelling Program A storytelling initiative that documents and elevates the voices of people living with sickle cell disease and their support systems to highlight resilience and eliminate stigma.
  • Advocacy Tools and Toolkits A collection of advocacy toolkits, state-specific resources, and interactive maps providing guidance for individuals to develop and implement sickle cell advocacy strategies at local and federal levels.
  • Sickle Cell Resources Library A comprehensive library of sickle cell disease education materials, data research, clinical guidelines, and treatment information for patients, caregivers, and medical professionals.
  • Hispanic Outreach Promoting Equity (HOPE) Project A project focused on understanding how race and ethnicity impact the experiences of Hispanic individuals with sickle cell disease, including educational tools and roundtable discussions.
  • Research Publications Reports, white papers, surveys, and research findings on Medicaid access, health equity, patient preferences, and the burden of sickle cell disease to drive advocacy work.
  • Caregiver Resources and Help Desk A partnership with Caregiver Action Network providing resources, a help desk, journey maps, and support services for caregivers of people living with sickle cell disease.

Quantifiable outcome

  • Over 100 SCD advocates recruited and engaged nationally through the Ambassador Program
  • +3 more outcomes

Companies that use Sick Cells

Customer profile

Segments6 records

Ideal customer profiles5 records

Sick Cells technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sick Cells partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and minor.

  • Sickle Cell Disease Association of America (SCDAA)coreStrategic or Co-development PartnerSick Cells is a member of the Sickle Cell Disease Association of America, a national organization representing the sickle cell community. Sick Cells collaborates with SCDAA on policy forums, legislative advocacy, and community organizing efforts.
  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerSick Cells holds Platinum membership in NORD, the leading independent organization representing the 25-30 million Americans with rare diseases. This membership supports Sick Cells' advocacy within the broader rare disease community.
  • Innovation and Value Initiative (IVI)coreStrategic or Co-development PartnerSick Cells partnered with IVI to publish a joint white paper on Finding Equity in Value, contributing the patient and sickle cell community perspective to value assessment methodologies in healthcare.
  • Sickle Cell Disease CoalitioncoreStrategic or Co-development PartnerSick Cells is a member of the Sickle Cell Disease Coalition, a group of organizations working to advance policies and research for the SCD community.
  • Blood Health Network (NHLBI)minorStrategic or Co-development PartnerSick Cells is a member of the Blood Health Network, an initiative of the National Heart, Lung, and Blood Institute (NHLBI) focused on blood health education and awareness.
  • Rare Hub by EveryLife FoundationminorStrategic or Co-development PartnerSick Cells participates in the Rare Hub by EveryLife Foundation, which provides resources and advocacy support for rare disease communities.
  • Vertex PharmaceuticalscoreStrategic or Co-development PartnerVertex Pharmaceuticals is a Silver Level sponsor of Sick Cells. Sick Cells collaborated with Vertex on the Health-Related Quality of Life Survey for sickle cell disease patients, and Vertex is developing gene therapies for SCD (exa-cel).
  • Quilt HealthcoreStrategic or Co-development PartnerQuilt Health is a Founder Level member of Sick Cells' Corporate Advisory Council, providing strategic support to the organization's mission.
  • University of PittsburghminorStrategic or Co-development PartnerSick Cells collaborated with the University of Pittsburgh to study barriers to accessing disease-modifying treatments for sickle cell disease.
  • Artia SolutionsminorImplementation/ SI/ Consulting PartnerSick Cells contracted Artia Solutions to conduct comprehensive analyses of coverage policies for SCD therapies across all 50 state Medicaid programs and managed care organizations.
  • University of Southern California Hematology Utilization Group Studies (USC HUGS)minorStrategic or Co-development PartnerSick Cells collaborated with USC HUGS as part of the PCORI Engagement Award to identify and assess core elements of value for SCD research measures.
  • Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of WashingtonminorStrategic or Co-development PartnerSick Cells collaborated with the CHOICE Institute at University of Washington School of Pharmacy on defining value and supporting equity in sickle cell disease research.
  • QC MedicaminorStrategic or Co-development PartnerSick Cells partnered with QC Medica to survey individuals living with sickle cell disease on the impacts of the disease on quality of life and health quality.
  • National Donor Marrow Program (NDMP)minorStrategic or Co-development PartnerSick Cells collaborated with NDMP and SC RED on the Transplant Equity and Awareness for Sickle Cell Disease (TEA for SCD) project to increase stem cell donation awareness.
  • Sickle Cell Reproductive Health Education Directive (SC RED)minorStrategic or Co-development PartnerSick Cells partnered with SC RED on the TEA for SCD project to raise awareness about bone marrow transplant as a treatment option for sickle cell disease.
  • Caregiver Action NetworkminorStrategic or Co-development PartnerSick Cells partnered with Caregiver Action Network to provide comprehensive resources and a Help Desk for sickle cell disease caregivers.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Sick Cells competitors and assessment

Company assessment

Direct peers

  • National Hemophilia Foundation: A chronic-disease patient advocacy nonprofit that combines research funding, policy advocacy, and community programs — a similar integrated advocacy model to Sick Cells, though serving hemophilia rather than SCD. Comparable in structure, funding mix (pharma + individual donations), and policy focus on payer access.
  • American Sickle Cell Anemia Association (ASCAA): A national SCD-focused nonprofit delivering patient education, community programs, and advocacy support. ASCAA is comparable to Sick Cells in mission and disease focus, with overlapping work in patient storytelling, awareness, and treatment-access advocacy.
  • EveryLife Foundation for Rare Diseases: A rare disease advocacy nonprofit focused on accelerating biotech innovation and access for rare disease communities. Directly comparable to Sick Cells in advocacy model — policy engagement, community mobilization, and federal agency comments — but operating across all rare diseases rather than a single condition.
  • Sickle Cell Disease Association of America (SCDAA): The longest-standing national SCD advocacy nonprofit, providing patient services, research, and policy advocacy. SCDAA is Sick Cells' most direct peer — both serve the same disease community with overlapping policy and community engagement mandates, though SCDAA is older and larger.
  • Sickle Cell Foundation of Georgia: A long-running regional SCD nonprofit providing patient education, support services, and advocacy. It is comparable to Sick Cells as a sickle cell-focused advocacy and community-support organization, though it operates at a state rather than national scale.

Broad incumbents

  • Susan G. Komen: A large disease-specific patient advocacy nonprofit combining research funding, community programs, and policy advocacy. Komen is a comparable model for Sick Cells at much greater scale, especially in grassroots mobilization and corporate partnership structures.
  • Muscular Dystrophy Association (MDA): A disease-specific patient advocacy nonprofit funding research, providing care services, and driving policy. MDA shares Sick Cells' integrated advocacy-plus-patient-services model and pharma-funded sponsorship structure, though at a much larger scale.
  • Cystic Fibrosis Foundation: A large disease-specific patient advocacy nonprofit that funds research, drives policy, and supports patients. Highly comparable to Sick Cells in the integrated advocacy-plus-research-plus-community model, though much larger and focused on CF rather than SCD.
  • National Organization for Rare Disorders (NORD): The largest US rare disease umbrella advocacy organization. Sick Cells holds Platinum membership in NORD; both engage in federal policy advocacy and community support, but NORD operates across all rare diseases while Sick Cells is disease-specific.

Others

  • Sickle Cell Disease Coalition: An umbrella coalition of SCD-focused organizations in which Sick Cells is a member. Comparable as a convening body that aligns SCD advocacy efforts across member organizations, serving as an enabling/ecosystem participant rather than a direct competitor.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Sick Cells social profiles

Digital presence

Sick Cells financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sick Cells leadership team

Management profile

Number of profiles

Profiles14 records

Sick Cells funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sick Cells M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sick Cells

What does Sick Cells do?

Sick Cells is a national 501(c)(3) nonprofit organization that advocates for the sickle cell disease (SCD) community through storytelling, policy engagement, and community organizing. The organization operates programs including the Ambassador Program, which trains volunteer SCD advocates, and the Faces of SCD Storytelling Program, which documents patient stories. It also produces research publications, advocacy toolkits, and educational resources provided free of charge to patients, caregivers, and policymakers.

Is Sick Cells a public or private company?

Sick Cells is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Sick Cells founded?

Sick Cells was founded in 2017. It employs 11 to 50 people.

Where is Sick Cells based?

Sick Cells is headquartered in Wheaton, United States, in the North America region.

How does Sick Cells make money?

Three revenue lines are on record. Individual Donations are the primary driver. The others are corporate Sponsorship and grant Funding.

Who are Sick Cells's main competitors?

Direct peers on record are National Hemophilia Foundation, American Sickle Cell Anemia Association (ASCAA), EveryLife Foundation for Rare Diseases, Sickle Cell Disease Association of America (SCDAA) and Sickle Cell Foundation of Georgia. Broad incumbents are Susan G. Komen, Muscular Dystrophy Association (MDA), Cystic Fibrosis Foundation and National Organization for Rare Disorders (NORD). Sickle Cell Disease Coalition is listed as an others.

Does Sick Cells have an API?

No public API is recorded for Sick Cells.

What industry is Sick Cells in?

Sick Cells's product category is Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAH, Patient Advocacy, Navigation & Access to Care, with a secondary code of BPAGACAM, Rare Disease & Special Needs Support Organizations. Its NAICS code is 6241 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales